Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 344

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 344
---
 | $    |              8,078 |

7.Leases

The Company has operating lease pertaining to square feet of corporate office space in Sugar Land, Texas pursuant to a lease agreement that commenced April 1, 2022. As of March 31, 2025 the remaining term of lease was years. The lease requires monthly lease payments that are subject to annual increases throughout the lease term.

The components of lease costs, which are included within general and administrative expenses in the Company’s condensed statements of operations and comprehensive loss were as follows (in thousands):

| ​                    
 ​                    
 ​                    
 Lease costs:         | ​ | ​                                    
 For the Three Months Ended March 31, 
 2025                                 
 ​                                    |  ​ | ​ | ​    
 2024 
 ​    |  ​ |
|:---------------------|:--|:-------------------------------------|---:|:--|:-----|---:|
| Operating lease cost | ​ | $                                    | 24 | ​ | $    | 22 |
| Variable lease cost  | ​ |                                      | 22 | ​ |      | 21 |
| Total lease costs    | ​ | $                                    | 46 | ​ | ​    | 43 |

Supplemental disclosure of cash flow information related to the lease were as follows (in thousands):

| ​                                          
 ​                                          | ​ 
 ​ | ​                                    
 For the Three Months Ended March 31, 
 ​                                    |    ​ 
 2025 | ​ | ​ |    ​ 
 2024 |
|:-------------------------------------------|:--|:-------------------------------------|-----:|:--|:--|-----:|
| Operating cash flows from operating leases | ​ | $                                    |   50 | ​ | $ |   49 |

The weighted-average discount rate and remaining lease term were as follows:

| ​                                     | ​ |                                    ​ | ​ |    ​ | ​ |
| ​                                     |   | For the Three Months Ended March 31, |   |      |   |
| ​                                     | ​ |                                 2025 |   | 2024 |   |
| Weighted-average discount rate        |   |                                 9.50 | % | 9.50 | % |
| Weighted-average remaining lease term |   |                                 2.33 |   | 3.33 | ​ |

F-39

#### As of March 31, 2025, the maturities of the Company’s operating lease liabilities were as follows